Table 1 Patients’ characteristics at baseline (n = 1,070)
From: Effect of menopause on the modified Rodnan skin score in systemic sclerosis
Characteristic | Value |
|---|---|
Menopausal status, n (%) | |
Premenopausal | 291 (28.1) |
Postmenopausal | 744 (71.9) |
Disease subtype, n (%) | |
Limited | 675 (65.0) |
Diffuse | 369 (35.0) |
Age, mean (SD) | 55.5 (11.7) |
Disease duration, mean (SD) | 11.2 (9.6) |
Modified Rodnan skin score, mean (SD) | |
Overall | 9.6 (9.1) |
Limited | 5.3 (4.2) |
Diffuse | 17.5 (10.1) |
Race/ethnicity, n (%) | |
White | 900 (84.3) |
Black | 7 (0.7) |
Other | 160 (15.0) |
Ever smokers, n (%) | 576 (53.8) |
Medication exposure, n (%) | |
Oral contraceptives, current use | 21 (2.0) |
Hormone replacement therapy, current use | 86 (8.2) |
DMARDs, current use | 183 (17.4) |
Cyclophosphamide, ever exposed | 85 (8.0) |